Roche: XELOX regimen may offer advantages over FOLFOX-4
Preliminary results show the combination of Xeloda plus Eloxatin, known as XELOX, to be equivalent to standard FOLFOX-4 chemotherapy treatment in terms of
Cancer News - CancerConsultants.com
XELOX and FOLFOX Produce Comparable Survival in Advanced Colorectal Cancer Related News: XELOX as Effective as FOLFOX in Advanced Colorectal Cancer
Tumore del colon in fase precoce: più alta incidenza di mortalità
Nel braccio XELOX + Avastin dello studio è stata osservata una più alta incidenza di Il regime XELOX si basa su Capecitabina ( Xeloda ) ed Oxaliplatino
Chemotherapy Drugs - List of Cancer Chemo Therapy Drugs
also view our chemotherapy drug list by drug name. Acronym: XELOX TIC TIP TIT Topo/CTX. V. VAB-6 VAC VAC/Adr VAD VATH VBMCP VeIP VIP VP. X. XELOX
University of Florida Shands Cancer Center: XELOX and FOLFOX
XELOX and FOLFOX Produce Comparable Survival in Advanced Colorectal Cancer XELOX was just as effective as FOLFOX in terms of progression-free survival.
Healthcare Sales & Marketing Network News: Results Show XELOX
News, Networking and Information for sales and marketing professionals in medical devices, pharmaceuticals and biotechnology: Results Show XELOX (Xeloda(R)
Chemotherapie - Wikipedia
Irinotecan (Wesentliche Nebenwirkung: Cholinerges Syndrom). XELOX ist ein dreiwöchentlicher Chemotherapiezyklus bestehenden aus folgenden Substanzen:
News - Xeloda plus Oxaliplatin (Xelox) Dramatically Reduces
Xeloda plus Oxaliplatin (Xelox) Dramatically Reduces Hospital Visits by Over 60%
Oxaliplatin and capecitabine (Xelox) in association with highly
The combination of oxaliplatin and capacitabine (Xelox) has been used in In the literature there is no report on the use of Xelox in the treatment of
Bevacizumab (Bev) in combination with XELOX or FOLFOX4: Efficacy
J Clin Oncol 2000;18:2938-47] or XELOX (oxaliplatin 130 mg/m2 iv, capecitabine 1000 Results: Median PFS for XELOX-Bev + FOLFOX4-Bev was 9.3 months vs.
XELOX equivalent patient survival compared with FOLFOX
Overall survival results from an international, phase III study (NO16966) suggest that XELOX (Xeloda plus oxaliplatin) is an effective alternative to the current standard treatment, FOLFOX-4 (infused 5-FU/leucovorin plus oxaliplatin),
Results Show XELOX XelodaR plus oxaliplatin Provides
22 (HSMN NewsFeed) -- Overall survival results from an international, Phase III study (NO16966) suggest that XELOX (Xeloda® plus oxaliplatin) is an effe Biopharmaceuticals, Oncology Roche , XELOX, Xeloda, oxaliplatin, FOLFOX-4,
Press Release: Results Show XELOX Provides Equivalent Overall
Press Release: Results Show XELOX Provides Equivalent Overall Patient Survival Compared To FOLFOX
International Phase III Study Revealed That XELOX Xeloda® +
Clinical data (from an international phase III study: NO16966) presented at the American Society of Clinical Oncology Gastrointestinal Symposium (ASCO GI) in Orlando, Florida suggest that XELOX (Xeloda® + oxaliplatin) is an effective
[Gastrointestinal Cancer] Multicenter Phase II Trial of
To evaluate the activity and safety of preoperative radiotherapy (RT) and concurrent capecitabine and oxaliplatin (XELOX-RT) plus four cycles of adjuvant XELOX in patients with rectal cancer. Patients and Methods
XELOX and FOLFOX Produce Comparable Survival in Advanced
According to results from a press release from Roche, as well as results presented at the 2007 annual meeting of the American Society of Clinical Oncology Gastrointestinal Symposium, the chemotherapy combination referred to as XELOX
Results Show XELOX XelodaR Plus Oxaliplatin Provides
Forum: Medical News Today Posted By: Angel Post Time: 01-23-2007 at 02:40 PM
XELOX plus radiotherapy effective for rectal cancer
Combined capecitabine and oxaliplatin plus pre-operative radiotherapy is an effective treatment for rectal cancer, study results demonstrate
[Gastrointestinal Cancer] Phase III Trial of Capecitabine Plus
To report the results of a planned safety analysis from a phase III trial comparing capecitabine plus oxaliplatin (XELOX) with bolus fluorouracil/leucovorin (FU/LV) as adjuvant therapy for stage III colon cancer. Patients and Methods
Results Show XELOX XelodaR Plus Oxaliplatin Provides
NUTLEY, NJ, Jan. 22 /PRNewswire/ -- Overall
xelox: , , xelox